H.E. Abdul Rahman bin Mohammed Al Owais, Minister of Health and Prevention, received a plaque from the Joint Commission International (JCI) following the accreditation of 213 UAE-based health centers. The accreditation marked another milestone in the UAE’s efforts to become a global leader in line with the UAE National Agenda leading to UAE Vision 2021. The plaque was bestowed on the Minister in recognition of his leadership as the Ministry continues to take strategic steps to apply the highest international standards. 

The Minister of Health & Prevention H.E. Abdul Rahman bin Mohammed Al Owais has issued the Ministerial Decree No. (28) of 2018 which details the mechanism for registering breakthrough and rare medicines after having obtained final approval from one of the accredited international regulatory authorities, pricing terms and obligations of the marketing authorization holder and importer of the medicines. The decree is in line with the Ministry's strategy to provide a legislative framework, regulatory and supervisory services for the health sector by creating health legislation in line with UAE Vision 2021.

The United Arab Emirates (UAE), with its more than 213 health facilities, has been ranked number one in the number of internationally accredited facilities by the Joint Commission International (JCI), once again highlighting its series of achievements and indices geared towards accomplishing the aspirations of the UAE Vision 2021 in order to strengthen its position on the global competitiveness map and take the lead in many international reports and indicators.

Under the Patronage of H.H. Sheikh Hamdan bin Rashid Al Maktoum, Deputy Ruler of Dubai, UAE Minister of Finance and President of Dubai Health Authority, the 11th GCC & 8th Emirates Otorhinolaryngology Audiology and Communication Disorders Conference opened at the InterContinental, Dubai Festival City. The ceremony was held in the presence of H.E. Humaid Mohammad Obaid Al Qutami, Director General, Dubai Health Authority; H.E. Dr. Hussein Abdel-Rahman Al Rand, Assistant Undersecretary for Health Clinics and Centers; as well as senior officials and leaders from the UAE’s, Gulf regions and global health sectors.

H.E Dr. Mohammad Salim Al Olama, Undersecretary of the UAE Ministry of Health and Prevention (MOHAP), met with H.E Frank Mollen, Ambassador of the Kingdom of the Netherlands to the United Arab Emirates, in the office of the Ministry in Abu Dhabi, in the presence of Dr. Issa Al Mansouri, Director of the Undersecretary Office and Director of the International Health Relations.

The Ministry of Health and Prevention (MOHAP) has warned health care practitioners and community members via a Circular No. 216 of 2017 about the risks involved in using silicone injections, which are falsely promoted as approved by the US Food and Drug Administration (FDA). Injections used to enhance the size of buttocks, breasts and other parts of the body can lead to serious injuries and irreversible deformities. In the circular sent to the directors of the medical districts, public and private hospitals, doctors, pharmacists and assistant pharmacists, and directors of public and private pharmacies, the Ministry recommends ensuring the safety of these products before using them. The FDA has made it clear that the only approved use for silicon injections is the silicon oil used in intraocular injection for some limited indications.